Nagoya, Japan

Yoshiro Ozeki


Average Co-Inventor Count = 6.6

ph-index = 1


Location History:

  • Aichi, JP (1995)
  • Nagoya, JP (1996)

Company Filing History:


Years Active: 1995-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yoshiro Ozeki: Innovator in Pharmaceutical Chemistry

Introduction

Yoshiro Ozeki is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents, Ozeki has focused on developing compounds that serve important medical purposes.

Latest Patents

Ozeki's latest patents include a 1-azabicyclo[3.3.0]octan derivative, which is a compound that has been identified as a hypermotility agent. This patent details a process for the preparation of the compound and its pharmacologically acceptable salts. Another significant patent involves benzopyrancarboxamide derivatives, which also includes a process for their preparation and potential uses in medicine. These innovations highlight Ozeki's commitment to advancing pharmaceutical applications.

Career Highlights

Yoshiro Ozeki is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been able to apply his expertise in developing new pharmaceutical compounds. His work has contributed to the advancement of medical treatments and has positioned him as a key figure in his field.

Collaborations

Ozeki has collaborated with notable colleagues such as Yutaka Baba and Toshinao Usui. These partnerships have likely enhanced the scope and impact of his research and innovations.

Conclusion

Yoshiro Ozeki's contributions to pharmaceutical chemistry through his patents demonstrate his innovative spirit and dedication to improving medical treatments. His work continues to influence the field and showcases the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…